Research progress of microvascular invasion in hepatocellular carcinoma.
10.3760/cma.j.cn501113-20210428-00211
- VernacularTitle:肝细胞癌微血管侵犯的研究进展
- Author:
Tao HE
1
;
Jie Yu ZOU
2
;
Ke SUN
1
;
Ting Ting LEI
1
;
Lin XU
1
Author Information
1. Department of Hepatobiliary Surgery, Second People's Hospital of Chengdu,Chengdu 610017, China.
2. The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China.
- Publication Type:Review
- MeSH:
Carcinoma, Hepatocellular/pathology*;
Humans;
Liver Neoplasms/pathology*;
Microvessels/pathology*;
Neoplasm Invasiveness/pathology*;
Prognosis;
Retrospective Studies
- From:
Chinese Journal of Hepatology
2022;30(8):899-904
- CountryChina
- Language:Chinese
-
Abstract:
Hepatocellular carcinoma (HCC) is a kind of highly aggressive tumor of the digestive system. Several studies have confirmed that microvascular invasion (MVI) is an independent risk factor for early recurrence and poor prognosis of HCC after surgery. Currently, pathological examination is the gold standard for diagnosing MVI. This paper summarizes concept, prognosis, preoperative prediction and treatment plan based on literature review of MVI in HCC.
